Guidelines
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative
Sheldon W. Tobe, James A. Stone, Melissa Brouwers, Onil Bhattacharyya, Kimberly M. Walker, Martin Dawes, Jacques Genest, Steven Grover, Gordon Gubitz, David Lau, Andrew Pipe, Peter Selby, Mark S. Tremblay, Darren E.R. Warburton, Richard Ward, Vincent Woo, Lawrence A. Leiter and Peter P. Liu
CMAJ October 18, 2011 183 (15) E1135-E1150; DOI: https://doi.org/10.1503/cmaj.101508
Sheldon W. Tobe
MD
James A. Stone
MD PhD
Melissa Brouwers
PhD
Onil Bhattacharyya
MD PhD
Kimberly M. Walker
BA
Martin Dawes
MD PhD
Jacques Genest Jr
MD
Steven Grover
MD MPA
Gordon Gubitz
MD
David Lau
MD PhD
Andrew Pipe
MD
Peter Selby
MBBS
Mark S. Tremblay
MD MSc
Darren E.R. Warburton
PhD
Richard Ward
MD
Vincent Woo
MD
Lawrence A. Leiter
MD
Peter P. Liu
MD
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data supplements
Online Appendices
Files in this Data Supplement:
Related Articles
- (2012). The C-CHANGE Initiative. CMAJ, 184(3), 327. Accessed July 30, 2024. https://doi.org/10.1503/cmaj.112-2015.
- (2011). Highlights. CMAJ, 183(15), 1685. Accessed July 30, 2024. Retrieved from http://www.cmaj.ca/content/183/15/1685.
In this issue
Article tools
Respond to this article
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative
Sheldon W. Tobe, James A. Stone, Melissa Brouwers, Onil Bhattacharyya, Kimberly M. Walker, Martin Dawes, Jacques Genest, Steven Grover, Gordon Gubitz, David Lau, Andrew Pipe, Peter Selby, Mark S. Tremblay, Darren E.R. Warburton, Richard Ward, Vincent Woo, Lawrence A. Leiter, Peter P. Liu
CMAJ Oct 2011, 183 (15) E1135-E1150; DOI: 10.1503/cmaj.101508
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative
Sheldon W. Tobe, James A. Stone, Melissa Brouwers, Onil Bhattacharyya, Kimberly M. Walker, Martin Dawes, Jacques Genest, Steven Grover, Gordon Gubitz, David Lau, Andrew Pipe, Peter Selby, Mark S. Tremblay, Darren E.R. Warburton, Richard Ward, Vincent Woo, Lawrence A. Leiter, Peter P. Liu
CMAJ Oct 2011, 183 (15) E1135-E1150; DOI: 10.1503/cmaj.101508
Jump to section
Related Articles
Cited By...
- Ligne directrice C-CHANGE pour lharmonisation des lignes directrices nationales de prevention et de prise en charge des maladies cardiovasculaires en contexte de soins primaires au Canada: mise a jour 2022
- Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update
- The Cardiovascular Health in Ambulatory Care Research Team performance indicators for the primary prevention of cardiovascular disease: a modified Delphi panel study
- The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial
- Mise a jour sur la prevention et le depistage selon lage a lintention des medecins de soins primaires canadiens
- Update on age-appropriate preventive measures and screening for Canadian primary care providers
- Lignes directrices simplifiees sur les lipides: Prevention et prise en charge des maladies cardiovasculaires en soins primaires
- Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care
- Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update
- Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice
- The C-CHANGE Initiative